MIF overexpression
|
GBM
|
MIF overexpression
|
GBM
|
aflibercept intravitreal Sensitive: C3 – Early Trials
|
aflibercept intravitreal Sensitive: C3 – Early Trials
|
MIF overexpression
|
NSCLC
|
MIF overexpression
|
NSCLC
|
EGFR inhibitor Resistant: C3 – Early Trials
|
EGFR inhibitor Resistant: C3 – Early Trials
|
MIF overexpression
|
Glioma
|
MIF overexpression
|
Glioma
|
temozolomide Resistant: D – Preclinical
|
temozolomide Resistant: D – Preclinical
|